Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-1,41%
1 076,13
-15,38
-1,41%
—1 091,511 090,401 090,401 073,69——
SIXC
Communications
SIXC
Communications
SIXC
-0,55%
606,74
-3,37
-0,55%
—610,11610,11610,29606,17——
SIXE
Energy
SIXE
Energy
SIXE
+0,88%
1 248,82
+10,84
+0,88%
—1 237,981 237,831 252,411 225,03——
SIXI
Industrials
SIXI
Industrials
SIXI
-1,17%
1 724,36
-20,35
-1,17%
—1 744,711 740,951 747,291 721,57——
SIXM
Financials
SIXM
Financials
SIXM
-0,72%
635,59
-4,59
-0,72%
—640,18639,92643,19634,73——
SIXR
Staples
SIXR
Staples
SIXR
-0,76%
843,15
-6,43
-0,76%
—849,58845,27851,68839,47——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,55%
216,29
-1,19
-0,55%
—217,48217,48218,16215,51——
SIXT
Technology
SIXT
Technology
SIXT
+0,08%
3 263,41
+2,72
+0,08%
—3 260,693 273,363 287,813 240,78——
SIXU
Utilities
SIXU
Utilities
SIXU
-0,34%
939,24
-3,21
-0,34%
—942,45939,39948,80933,98——
SIXV
Health care
SIXV
Health care
SIXV
-0,29%
1 462,56
-4,24
-0,29%
—1 466,801 464,701 467,191 458,36——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0,71%
2 380,40
-17,10
-0,71%
—2 397,502 395,032 412,012 370,64——
INM:NASDAQ
InMed Pharmaceuticals Inc
0,75 USD
+4,73%
(+0,034) 1D
4-май, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for INM...
Open
0,71 USD
High
0,78 USD
Low
0,71 USD
Mkt. cap
2,48 млн
Avg. vol.
127,33 миң
Volume
5,65 миң
52-wk high
7,98 USD
52-wk low
0,58 USD
EPS
-4,08 USD
Beta
0,57
Shares outstanding
3,31 млн
No. of employees
13
News stories
From sources across the web
About InMed Pharmaceuticals Inc
CEOEric A. Adams
Employees13
Founded1981
HeadquartersВанкувер, Бритиш Колумбия, Канада
SectorPharmaceutical industry
Websiteinmedpharma.com
Previous reportsAll values in CAD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
2025-ж. мар.
2025-ж. июн.
2025-ж. сен.
2025-ж. дек.
Revenue
1,26 млн
1,30 млн
1,12 млн
820,19 миң
Cost of goods sold
1,09 млн
728,06 миң
716,96 миң
635,99 миң
Cost of revenue
1,09 млн
728,06 миң
716,96 миң
635,99 миң
Research and development expenses
909,65 миң
112,72 миң
581,61 миң
630,64 миң
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,33 млн
2,25 млн
1,53 млн
1,62 млн
Operating expense
2,29 млн
2,42 млн
2,17 млн
2,30 млн
Total operating expenses
3,38 млн
3,15 млн
2,88 млн
2,94 млн
Operating income
-2,12 млн
-1,84 млн
-1,76 млн
-2,12 млн
Other non operating income
-
-
-
-
EBT including unusual items
-2,12 млн
-1,79 млн
-1,73 млн
-2,03 млн
EBT excluding unusual items
-2,12 млн
-1,79 млн
-1,73 млн
-2,03 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-2,12 млн
-1,79 млн
-1,73 млн
-2,03 млн
Net profit margin
-168,12%
-137,07%
-154,17%
-247,29%
Earnings per share
-
-
-
-
Interest and investment income
16,56 миң
51,69 миң
93,76 миң
74,38 миң
Interest expense
-
-20,00 миң
-
-
Net interest expenses
16,56 миң
31,69 миң
93,76 миң
74,38 миң
Depreciation and amortization charges
52,31 миң
52,75 миң
53,20 миң
53,20 миң
EBITDA
-2,06 млн
-1,79 млн
-1,71 млн
-2,07 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer